GLIMEPIRIDE

GLIMEPIRIDE was reported 39066 times

GLIMEPIRIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD LACTIC ACID 20 0.1550
1 HYPOGLYCAEMIC ENCEPHALOPATHY 53 0.1362
2 HYPOGLYCAEMIC COMA 219 0.0759
3 DIABETIC METABOLIC DECOMPENSATION 74 0.0533
4 NECROTISING OESOPHAGITIS 23 0.0461
5 NEPHROGENIC ANAEMIA 198 0.0427
6 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 44 0.0414
7 HYPERPARATHYROIDISM SECONDARY 94 0.0375
8 EOSINOPHILIC MYOCARDITIS 27 0.0370
9 HYPOGLYCAEMIA 1693 0.0349
10 BRASH SYNDROME 44 0.0313
11 GASTROINTESTINAL HYPOMOTILITY 68 0.0301
12 DIABETES MELLITUS INADEQUATE CONTROL 485 0.0274
13 GLYCOSYLATED HAEMOGLOBIN INCREASED 657 0.0260
14 REBOUND ACID HYPERSECRETION 77 0.0254
15 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 27 0.0243
16 GLYCOSYLATED HAEMOGLOBIN DECREASED 39 0.0242
17 EUGLYCAEMIC DIABETIC KETOACIDOSIS 90 0.0218
18 LACTIC ACIDOSIS 663 0.0205
19 BLOOD GLUCOSE DECREASED 972 0.0202
20 DIABETIC NEUROPATHY 100 0.0202
21 ADENOCARCINOMA PANCREAS 25 0.0195
22 EARLY SATIETY 37 0.0190
23 IMPAIRED GASTRIC EMPTYING 254 0.0186
24 BLOOD GLUCOSE FLUCTUATION 198 0.0180
25 PANCREATIC CARCINOMA METASTATIC 51 0.0179
26 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 21 0.0175
27 HYPOGLYCAEMIC UNCONSCIOUSNESS 33 0.0166
28 END STAGE RENAL DISEASE 301 0.0165
29 INJECTION SITE NODULE 177 0.0161
30 BLOOD GLUCOSE INCREASED 3015 0.0160
31 DIABETIC RETINOPATHY 54 0.0159
32 DIABETIC NEPHROPATHY 34 0.0154
33 BLOOD GLUCOSE ABNORMAL 275 0.0149
34 BLADDER TRANSITIONAL CELL CARCINOMA 20 0.0140
35 PANCREATITIS NECROTISING 32 0.0139
36 VENOUS OCCLUSION 25 0.0137
37 METABOLIC ALKALOSIS 21 0.0131
38 CHRONIC KIDNEY DISEASE 909 0.0120
39 INTENTIONAL DEVICE MISUSE 52 0.0118
40 ESSENTIAL HYPERTENSION 20 0.0109
41 AZOTAEMIA 43 0.0108
42 CAROTID ARTERY STENOSIS 36 0.0103
43 PANCREATITIS ACUTE 223 0.0099
44 HYPERGLYCAEMIA 354 0.0097
45 PANCREATITIS CHRONIC 23 0.0097
46 DIABETIC KETOACIDOSIS 233 0.0097
47 COMPARTMENT SYNDROME 25 0.0096
48 HAEMORRHAGIC ANAEMIA 42 0.0095
49 CORONARY ARTERY STENOSIS 48 0.0095
50 POTENTIATING DRUG INTERACTION 32 0.0095
51 HYPERKALAEMIA 332 0.0095
52 HYPOTHERMIA 95 0.0094
53 INJECTION SITE EXTRAVASATION 108 0.0087
54 METABOLIC ENCEPHALOPATHY 26 0.0087
55 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 35 0.0086
56 PEMPHIGOID 64 0.0085
57 ACUTE KIDNEY INJURY 1268 0.0083
58 ERUCTATION 158 0.0082
59 BRADYPNOEA 22 0.0081
60 URINE OUTPUT INCREASED 21 0.0080
61 LIPASE INCREASED 61 0.0080
62 PANCREATIC DISORDER 39 0.0079
63 METABOLIC ACIDOSIS 248 0.0077
64 BLOOD LACTIC ACID INCREASED 40 0.0076
65 OLIGURIA 46 0.0074
66 RENAL FAILURE 972 0.0073
67 NEPHROPATHY 68 0.0073
68 TESTICULAR PAIN 23 0.0072
69 HYPERKERATOSIS 40 0.0072
70 DERMATITIS EXFOLIATIVE 36 0.0072
71 NECROTISING FASCIITIS 25 0.0071
72 JAUNDICE CHOLESTATIC 25 0.0071
73 AMYLASE INCREASED 26 0.0070
74 TUBULOINTERSTITIAL NEPHRITIS 132 0.0070
75 ABNORMAL LOSS OF WEIGHT 48 0.0070
76 RENAL TUBULAR NECROSIS 68 0.0069
77 RENAL INJURY 205 0.0069
78 DIABETES MELLITUS 523 0.0069
79 ISCHAEMIC CARDIOMYOPATHY 21 0.0068
80 HYPERTHYROIDISM 99 0.0068
81 GLOMERULAR FILTRATION RATE DECREASED 84 0.0068
82 BLOOD PRESSURE INADEQUATELY CONTROLLED 41 0.0068
83 KETOACIDOSIS 51 0.0068
84 CARDIAC FAILURE ACUTE 45 0.0067
85 ANURIA 56 0.0065
86 CEREBRAL INFARCTION 158 0.0065
87 RENAL FAILURE ACUTE 273 0.0064
88 ARTERIAL OCCLUSIVE DISEASE 50 0.0064
89 PANCREATITIS 335 0.0063
90 VULVOVAGINAL PRURITUS 32 0.0063
91 TOE AMPUTATION 32 0.0063
92 RENAL CYST 50 0.0063
93 ALTERED STATE OF CONSCIOUSNESS 135 0.0062
94 PULSELESS ELECTRICAL ACTIVITY 26 0.0062
95 TYPE 2 DIABETES MELLITUS 209 0.0062
96 BLOOD POTASSIUM INCREASED 100 0.0062
97 CARDIAC FAILURE CHRONIC 26 0.0061
98 LEFT VENTRICULAR FAILURE 21 0.0061
99 CATARACT OPERATION 36 0.0061
100 ELECTROLYTE IMBALANCE 70 0.0060
101 HYPERPHAGIA 24 0.0060
102 HYPERTRIGLYCERIDAEMIA 35 0.0060
103 DUODENAL ULCER 42 0.0059
104 DYSLIPIDAEMIA 30 0.0059
105 RENAL FAILURE CHRONIC 45 0.0058
106 CORONARY ARTERY OCCLUSION 80 0.0058
107 ATRIOVENTRICULAR BLOCK COMPLETE 39 0.0058
108 INJECTION SITE MASS 215 0.0058
109 SUSPECTED SUICIDE 27 0.0058
110 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 22 0.0058
111 ACIDOSIS 44 0.0058
112 COLD SWEAT 100 0.0057
113 BLOOD TRIGLYCERIDES INCREASED 100 0.0057
114 HEPATIC STEATOSIS 105 0.0056
115 HAEMORRHAGIC STROKE 44 0.0056
116 BODY HEIGHT DECREASED 60 0.0056
117 HYPOMAGNESAEMIA 78 0.0056
118 PROSTATOMEGALY 22 0.0056
119 IDIOPATHIC PULMONARY FIBROSIS 22 0.0056
120 LOWER GASTROINTESTINAL HAEMORRHAGE 41 0.0055
121 UPPER GASTROINTESTINAL HAEMORRHAGE 93 0.0055
122 HYPERLIPIDAEMIA 66 0.0055
123 DRUG LEVEL INCREASED 91 0.0055
124 DIVERTICULUM INTESTINAL 24 0.0055
125 CORONARY ARTERY DISEASE 166 0.0055
126 THYROID MASS 21 0.0055
127 CHOLECYSTITIS ACUTE 31 0.0055
128 HYPOVOLAEMIA 32 0.0055
129 VITAMIN B12 DEFICIENCY 22 0.0054
130 ESCHERICHIA URINARY TRACT INFECTION 23 0.0054
131 HYPERVENTILATION 31 0.0053
132 DEHYDRATION 713 0.0053
133 BLINDNESS TRANSIENT 39 0.0053
134 OESOPHAGEAL CANDIDIASIS 21 0.0053
135 HEPATOCELLULAR CARCINOMA 40 0.0053
136 RENAL IMPAIRMENT 440 0.0052
137 ANGINA UNSTABLE 34 0.0052
138 BENIGN PROSTATIC HYPERPLASIA 27 0.0052
139 ACUTE RESPIRATORY FAILURE 100 0.0052
140 BLOOD CHOLESTEROL ABNORMAL 24 0.0052
141 SHOCK 119 0.0052
142 INJECTION SITE HAEMORRHAGE 413 0.0052
143 WEIGHT FLUCTUATION 54 0.0052
144 DECREASED APPETITE 1190 0.0051
145 HUNGER 71 0.0051
146 MYOCARDIAL ISCHAEMIA 58 0.0051
147 LEG AMPUTATION 21 0.0051
148 WEIGHT DECREASED 1419 0.0051
149 GASTROENTERITIS 74 0.0051
150 PERIPHERAL VASCULAR DISORDER 26 0.0050
151 CHOLECYSTITIS 60 0.0050
152 BLOOD MAGNESIUM DECREASED 43 0.0050
153 BUNDLE BRANCH BLOCK LEFT 21 0.0049
154 ACUTE MYOCARDIAL INFARCTION 146 0.0049
155 ACCIDENTAL UNDERDOSE 71 0.0049
156 ATRIOVENTRICULAR BLOCK 38 0.0049
157 BLOOD UREA INCREASED 82 0.0049
158 IRON DEFICIENCY ANAEMIA 45 0.0049
159 CEREBRAL ISCHAEMIA 25 0.0049
160 BLOOD URIC ACID INCREASED 28 0.0048
161 MONOPLEGIA 21 0.0048
162 INABILITY TO AFFORD MEDICATION 48 0.0048
163 CARDIAC FAILURE CONGESTIVE 387 0.0048
164 PROTEIN URINE PRESENT 24 0.0048
165 GASTROINTESTINAL HAEMORRHAGE 402 0.0048
166 SLEEP APNOEA SYNDROME 91 0.0048
167 PSYCHOLOGICAL TRAUMA 41 0.0047
168 RENAL FUNCTION TEST ABNORMAL 22 0.0047
169 HEPATIC CIRRHOSIS 89 0.0047
170 VENTRICULAR TACHYCARDIA 78 0.0047
171 CATARACT 280 0.0047
172 ABSCESS LIMB 20 0.0047
173 ARTERIOSCLEROSIS CORONARY ARTERY 31 0.0047
174 SPINAL COLUMN STENOSIS 22 0.0047
175 POLYURIA 38 0.0046
176 HALLUCINATION, VISUAL 97 0.0046
177 HYPOVOLAEMIC SHOCK 22 0.0046
178 SUBCUTANEOUS ABSCESS 22 0.0046
179 HEPATOMEGALY 45 0.0046
180 BUNDLE BRANCH BLOCK RIGHT 21 0.0046
181 HEMIPLEGIA 38 0.0046
182 FUNGAL INFECTION 152 0.0046
183 DECUBITUS ULCER 37 0.0045
184 CHOLANGITIS 28 0.0045
185 CHOLELITHIASIS 148 0.0045
186 POLLAKIURIA 188 0.0045
187 ILEUS 56 0.0045
188 DIVERTICULUM 32 0.0045
189 VENTRICULAR FIBRILLATION 50 0.0045
190 TIBIA FRACTURE 21 0.0045
191 CARDIOMEGALY 55 0.0045
192 ARTERIOSCLEROSIS 42 0.0045
193 VITAMIN D DEFICIENCY 43 0.0044
194 LOW DENSITY LIPOPROTEIN INCREASED 34 0.0044
195 ABDOMINAL HERNIA 20 0.0044
196 INFARCTION 30 0.0044
197 ISCHAEMIC STROKE 78 0.0044
198 PANCREATIC CARCINOMA 126 0.0044
199 HYPOPHAGIA 111 0.0043
200 AMMONIA INCREASED 22 0.0043
201 BLOOD SODIUM DECREASED 81 0.0043
202 RENAL DISORDER 200 0.0043
203 GOUT 77 0.0043
204 ANEURYSM 21 0.0042
205 HYPERNATRAEMIA 21 0.0042
206 RETINAL HAEMORRHAGE 30 0.0042
207 CARDIAC PACEMAKER INSERTION 25 0.0042
208 PRE-EXISTING CONDITION IMPROVED 26 0.0042
209 GANGRENE 25 0.0041
210 BRADYCARDIA 219 0.0041
211 URINE OUTPUT DECREASED 36 0.0041
212 SPLENOMEGALY 48 0.0041
213 CONSTIPATION 893 0.0041
214 BLOOD CREATININE INCREASED 267 0.0041
215 ELECTROCARDIOGRAM ABNORMAL 32 0.0041
216 UNRESPONSIVE TO STIMULI 105 0.0041
217 SKIN ULCER 105 0.0041
218 METASTASES TO LIVER 71 0.0040
219 BASAL CELL CARCINOMA 63 0.0040
220 FLATULENCE 228 0.0040
221 UROSEPSIS 37 0.0040
222 DYSPEPSIA 394 0.0040
223 SQUAMOUS CELL CARCINOMA OF SKIN 24 0.0040
224 LOCALISED INFECTION 96 0.0040
225 STENT PLACEMENT 32 0.0040
226 INJECTION SITE INJURY 22 0.0040
227 ATRIAL FIBRILLATION 386 0.0040
228 NOCTURIA 48 0.0040
229 DIALYSIS 56 0.0039
230 HAEMODIALYSIS 33 0.0039
231 LEUKOCYTOSIS 71 0.0039
232 PROSTATIC SPECIFIC ANTIGEN INCREASED 54 0.0039
233 HAEMATURIA 134 0.0039
234 OVERWEIGHT 21 0.0039
235 INJECTION SITE DISCOMFORT 41 0.0039
236 PROTEINURIA 74 0.0039
237 HAIR DISORDER 32 0.0039
238 LEFT VENTRICULAR DYSFUNCTION 26 0.0039
239 HYDRONEPHROSIS 29 0.0039
240 INCREASED APPETITE 74 0.0039
241 DRUG INTERACTION 614 0.0039
242 PULMONARY CONGESTION 51 0.0039
243 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 34 0.0038
244 GALLBLADDER DISORDER 68 0.0038
245 PYELONEPHRITIS 33 0.0038
246 NEPHROLITHIASIS 174 0.0038
247 INCONTINENCE 40 0.0038
248 ANGINA PECTORIS 108 0.0038
249 OEDEMA PERIPHERAL 459 0.0038
250 HOSPICE CARE 37 0.0037
251 GASTROOESOPHAGEAL REFLUX DISEASE 300 0.0037
252 DYSURIA 137 0.0037
253 ANAL ABSCESS 20 0.0037
254 METASTASES TO LYMPH NODES 25 0.0037
255 PRURITUS GENERALISED 80 0.0037
256 THIRST 66 0.0037
257 DYSARTHRIA 139 0.0037
258 RHABDOMYOLYSIS 153 0.0037
259 ANAL INCONTINENCE 33 0.0037
260 CARDIAC FAILURE 294 0.0037
261 BLOOD TESTOSTERONE DECREASED 25 0.0037
262 HYPOKALAEMIA 168 0.0036
263 FACIAL PARALYSIS 31 0.0036
264 BLOOD IRON DECREASED 43 0.0036
265 COLON CANCER 54 0.0036
266 FULL BLOOD COUNT DECREASED 73 0.0036
267 ACUTE CORONARY SYNDROME 30 0.0036
268 MADAROSIS 42 0.0036
269 CONCUSSION 28 0.0036
270 EATING DISORDER 77 0.0036
271 INTERVERTEBRAL DISC PROTRUSION 79 0.0036
272 INTERNATIONAL NORMALISED RATIO INCREASED 103 0.0036
273 GASTRIC ULCER HAEMORRHAGE 20 0.0036
274 NERVE INJURY 40 0.0036
275 URINARY TRACT INFECTION 613 0.0036
276 OSTEOMYELITIS 65 0.0036
277 MICTURITION URGENCY 41 0.0036
278 HYPERCALCAEMIA 44 0.0036
279 DIARRHOEA 2288 0.0035
280 ENCEPHALOPATHY 87 0.0035
281 ERYTHEMA MULTIFORME 33 0.0035
282 HAIR COLOUR CHANGES 44 0.0035
283 HAEMATOCRIT DECREASED 70 0.0035
284 BLOOD URINE PRESENT 67 0.0035
285 ANAEMIA 672 0.0035
286 HYPERCHOLESTEROLAEMIA 34 0.0035
287 HYPONATRAEMIA 198 0.0035
288 POLYP 23 0.0035
289 SCIATICA 56 0.0035
290 DIZZINESS POSTURAL 34 0.0035
291 THYROID DISORDER 54 0.0035
292 NEPHROTIC SYNDROME 24 0.0035
293 INTERNAL HAEMORRHAGE 40 0.0035
294 RED BLOOD CELL COUNT DECREASED 100 0.0035
295 ECONOMIC PROBLEM 53 0.0035
296 BACK INJURY 38 0.0035
297 MENTAL STATUS CHANGES 97 0.0035
298 BLOOD POTASSIUM DECREASED 105 0.0035
299 RECTAL HAEMORRHAGE 150 0.0035
300 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 182 0.0035
301 COAGULOPATHY 58 0.0035
302 INCREASED TENDENCY TO BRUISE 32 0.0035
303 DIVERTICULITIS 96 0.0035
304 TACHYPNOEA 47 0.0035
305 SUPRAVENTRICULAR TACHYCARDIA 33 0.0034
306 MUSCULOSKELETAL DISCOMFORT 59 0.0034
307 FEELING JITTERY 65 0.0034
308 VITAMIN D DECREASED 29 0.0034
309 GLUCOSE TOLERANCE IMPAIRED 20 0.0034
310 ARTHROPOD BITE 25 0.0034
311 EYE HAEMORRHAGE 45 0.0034
312 ABDOMINAL DISTENSION 352 0.0034
313 PRODUCT DOSE OMISSION 220 0.0034
314 UNDERDOSE 246 0.0034
315 FAECES DISCOLOURED 73 0.0034
316 TOXIC EPIDERMAL NECROLYSIS 51 0.0034
317 VITREOUS FLOATERS 33 0.0034
318 DYSSTASIA 98 0.0034
319 TASTE DISORDER 68 0.0033
320 ROTATOR CUFF SYNDROME 43 0.0033
321 WALKING AID USER 22 0.0033
322 SLUGGISHNESS 34 0.0033
323 FALL 1109 0.0033
324 SOPOR 44 0.0033
325 LARGE INTESTINE POLYP 23 0.0033
326 APPETITE DISORDER 22 0.0033
327 ACCIDENTAL OVERDOSE 121 0.0033
328 DISORIENTATION 131 0.0033
329 FEEDING DISORDER 67 0.0033
330 URINARY RETENTION 110 0.0033
331 DYSPNOEA EXERTIONAL 124 0.0033
332 EXOSTOSIS 30 0.0033
333 HYPERHIDROSIS 423 0.0033
334 CARDIAC ARREST 271 0.0033
335 HYPOCALCAEMIA 62 0.0033
336 SPINAL COMPRESSION FRACTURE 27 0.0033
337 BOWEL MOVEMENT IRREGULARITY 25 0.0033
338 GASTRIC ULCER 62 0.0033
339 TRANSIENT ISCHAEMIC ATTACK 110 0.0033
340 ORAL PAIN 73 0.0033
341 WHITE BLOOD CELL COUNT INCREASED 125 0.0033
342 CARDIAC OPERATION 28 0.0033
343 ASTHENIA 1223 0.0032
344 CARDIAC FLUTTER 21 0.0032
345 URINARY INCONTINENCE 96 0.0032
346 BLOOD CHOLESTEROL INCREASED 151 0.0032
347 CHOLECYSTECTOMY 37 0.0032
348 PULMONARY OEDEMA 145 0.0032
349 CARDIAC MURMUR 28 0.0032
350 ABDOMINAL PAIN UPPER 666 0.0032
351 HAEMORRHOIDS 63 0.0032
352 SKIN LACERATION 35 0.0032
353 HAEMOGLOBIN DECREASED 330 0.0032
354 CYSTITIS 102 0.0032
355 CELLULITIS 161 0.0032
356 BLOOD CALCIUM INCREASED 28 0.0032
357 MACULAR DEGENERATION 38 0.0032
358 SEASONAL ALLERGY 45 0.0032
359 PLEURAL EFFUSION 193 0.0032
360 FLUID RETENTION 161 0.0032
361 HAEMATOMA 82 0.0032
362 LOSS OF CONSCIOUSNESS 404 0.0031
363 BODY TEMPERATURE DECREASED 31 0.0031
364 DRUG DOSE OMISSION 520 0.0031
365 HAIR TEXTURE ABNORMAL 42 0.0031
366 ATRIAL FLUTTER 25 0.0031
367 AGEUSIA 78 0.0031
368 PRESYNCOPE 76 0.0031
369 INTERSTITIAL LUNG DISEASE 151 0.0031
370 MULTIPLE ORGAN DYSFUNCTION SYNDROME 88 0.0031
371 PERIPHERAL SWELLING 478 0.0031
372 RETCHING 66 0.0031
373 FLANK PAIN 29 0.0031
374 BLOOD CREATINE PHOSPHOKINASE INCREASED 89 0.0031
375 EOSINOPHILIA 54 0.0031
376 VENTRICULAR EXTRASYSTOLES 32 0.0031
377 BLOOD PRESSURE SYSTOLIC INCREASED 60 0.0031
378 CARPAL TUNNEL SYNDROME 43 0.0031
379 NODULE 40 0.0031
380 INJECTION SITE IRRITATION 39 0.0031
381 EPISTAXIS 229 0.0031
382 DECREASED ACTIVITY 33 0.0031
383 HYPERTENSION 647 0.0031
384 PNEUMONIA ASPIRATION 76 0.0030
385 MALNUTRITION 34 0.0030
386 HYPOTHYROIDISM 97 0.0030
387 SKIN HAEMORRHAGE 45 0.0030
388 BLOOD PRESSURE ABNORMAL 60 0.0030
389 HEMIPARESIS 51 0.0030
390 TREMOR 499 0.0030
391 EOSINOPHIL COUNT INCREASED 25 0.0030
392 SPINAL FRACTURE 60 0.0030
393 NAUSEA 2370 0.0030
394 TOOTH FRACTURE 33 0.0030
395 LIMB INJURY 81 0.0030
396 INCORRECT PRODUCT STORAGE 39 0.0030
397 DRUG PRESCRIBING ERROR 57 0.0030
398 HYPERTENSIVE CRISIS 33 0.0030
399 HYPERSOMNIA 85 0.0030
400 INJECTION SITE DISCOLOURATION 37 0.0030
401 CEREBRAL HAEMORRHAGE 106 0.0030
402 SPINAL OSTEOARTHRITIS 26 0.0030
403 INJECTION SITE BRUISING 236 0.0030
404 MELAENA 65 0.0030
405 BACK DISORDER 48 0.0029
406 MULTI-ORGAN FAILURE 51 0.0029
407 SHOCK HAEMORRHAGIC 24 0.0029
408 BRONCHITIS 218 0.0029
409 METASTASES TO LUNG 34 0.0029
410 HYPOTENSION 590 0.0029
411 ABDOMINAL DISCOMFORT 493 0.0029
412 RETINAL DETACHMENT 27 0.0029
413 CIRCULATORY COLLAPSE 50 0.0029
414 GASTROENTERITIS VIRAL 53 0.0029
415 VOMITING 1380 0.0029
416 HIATUS HERNIA 38 0.0029
417 BLOOD CALCIUM DECREASED 33 0.0029
418 CARDIOGENIC SHOCK 42 0.0029
419 RENAL PAIN 31 0.0029
420 BLADDER DISORDER 29 0.0029
421 DISSEMINATED INTRAVASCULAR COAGULATION 41 0.0029
422 HAEMOLYTIC ANAEMIA 26 0.0029
423 BLOOD COUNT ABNORMAL 44 0.0029
424 NEUROPATHY PERIPHERAL 276 0.0029
425 BLOOD ALBUMIN DECREASED 23 0.0029
426 SEPSIS 323 0.0029
427 SYNCOPE 289 0.0029
428 GASTRITIS 76 0.0029
429 CONFUSIONAL STATE 465 0.0029
430 DRY MOUTH 233 0.0029
431 NERVOUSNESS 150 0.0029
432 BLOOD DISORDER 23 0.0029
433 RIB FRACTURE 59 0.0029
434 SQUAMOUS CELL CARCINOMA 27 0.0029
435 HYPOXIA 101 0.0029
436 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 204 0.0029
437 WEIGHT INCREASED 642 0.0029
438 EXTRASYSTOLES 20 0.0029
439 PNEUMONIA 927 0.0029
440 DRY THROAT 29 0.0029
441 HEAD INJURY 90 0.0028
442 PARAESTHESIA ORAL 41 0.0028
443 PLATELET COUNT INCREASED 37 0.0028
444 HYPOACUSIS 122 0.0028
445 VISUAL ACUITY REDUCED 94 0.0028
446 HYPOALBUMINAEMIA 22 0.0028
447 BLOOD PRESSURE DECREASED 188 0.0028
448 DEMENTIA 79 0.0028
449 MEDICATION ERROR 157 0.0028
450 OBESITY 45 0.0028
451 DIZZINESS 1407 0.0028
452 PULMONARY MASS 42 0.0028
453 CEREBROVASCULAR ACCIDENT 477 0.0028
454 BLOOD PRESSURE INCREASED 430 0.0028
455 INTERVERTEBRAL DISC DEGENERATION 26 0.0028
456 INTENTIONAL OVERDOSE 180 0.0028
457 DYSPHONIA 164 0.0028
458 MYOCARDIAL INFARCTION 489 0.0028
459 HAEMATEMESIS 71 0.0028
460 COVID-19 PNEUMONIA 33 0.0028
461 ANOREXIA 36 0.0028
462 CHROMATURIA 63 0.0028
463 WOUND 78 0.0028
464 HEART RATE IRREGULAR 63 0.0028
465 HEPATIC FUNCTION ABNORMAL 104 0.0028
466 ARTHRITIS 219 0.0028
467 PAROSMIA 21 0.0028
468 ANKLE FRACTURE 43 0.0028
469 PARKINSONISM 27 0.0028
470 GAIT DISTURBANCE 530 0.0028
471 UPPER LIMB FRACTURE 55 0.0028
472 CHOLESTASIS 53 0.0028
473 INJECTION SITE HAEMATOMA 40 0.0028
474 ASCITES 81 0.0028
475 SUBARACHNOID HAEMORRHAGE 28 0.0027
476 ARRHYTHMIA 130 0.0027
477 BALANCE DISORDER 237 0.0027
478 MITRAL VALVE INCOMPETENCE 31 0.0027
479 HEART RATE DECREASED 96 0.0027
480 PNEUMONIA BACTERIAL 25 0.0027
481 PLATELET COUNT DECREASED 290 0.0027
482 RASH PRURITIC 147 0.0027
483 DRUG ERUPTION 48 0.0027
484 MUSCULAR WEAKNESS 307 0.0027
485 KIDNEY INFECTION 53 0.0027
486 GLAUCOMA 52 0.0027
487 FEELING DRUNK 20 0.0027
488 FLUID OVERLOAD 39 0.0027
489 INTESTINAL OBSTRUCTION 101 0.0027
490 DYSGEUSIA 199 0.0027
491 ABDOMINAL PAIN 623 0.0027
492 EMPHYSEMA 27 0.0027
493 NEPHROPATHY TOXIC 30 0.0027
494 JOINT INJURY 57 0.0027
495 GENERALISED OEDEMA 33 0.0027
496 MUSCLE STRAIN 23 0.0027
497 SCRATCH 28 0.0027
498 MEMORY IMPAIRMENT 364 0.0026
499 IMPAIRED QUALITY OF LIFE 38 0.0026
500 TRICUSPID VALVE INCOMPETENCE 21 0.0026
501 BLISTER 148 0.0026
502 BACK PAIN 612 0.0026
503 LIGAMENT SPRAIN 26 0.0026
504 AORTIC ANEURYSM 20 0.0026
505 SINUS DISORDER 52 0.0026
506 PERIPHERAL COLDNESS 36 0.0026
507 OSTEOARTHRITIS 111 0.0026
508 LIMB DISCOMFORT 81 0.0026
509 DRUG EFFECT INCOMPLETE 95 0.0026
510 CANDIDA INFECTION 44 0.0026
511 DEPRESSED LEVEL OF CONSCIOUSNESS 103 0.0026
512 PULMONARY HYPERTENSION 54 0.0026
513 ATELECTASIS 25 0.0026
514 ORTHOSTATIC HYPOTENSION 45 0.0026
515 INJECTION SITE PRURITUS 173 0.0026
516 VISUAL IMPAIRMENT 320 0.0026
517 COMPLETED SUICIDE 215 0.0026
518 TOOTH INFECTION 34 0.0026
519 PRODUCT ODOUR ABNORMAL 27 0.0026
520 NEEDLE ISSUE 75 0.0026
521 RHINORRHOEA 166 0.0026
522 PULMONARY THROMBOSIS 28 0.0026
523 RESPIRATORY FAILURE 187 0.0026
524 SPINAL PAIN 30 0.0026
525 DEVICE LEAKAGE 111 0.0026
526 SPEECH DISORDER 134 0.0026
527 DRUG DISPENSING ERROR 39 0.0025
528 DRUG-INDUCED LIVER INJURY 80 0.0025
529 OEDEMA 138 0.0025
530 GENERALISED TONIC-CLONIC SEIZURE 42 0.0025
531 HOT FLUSH 191 0.0025
532 INTENTIONAL PRODUCT MISUSE 221 0.0025
533 INJECTION SITE PAIN 770 0.0025
534 GROIN PAIN 22 0.0025
535 WRIST FRACTURE 30 0.0025
536 INFLUENZA 279 0.0025
537 NERVE COMPRESSION 23 0.0025
538 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 58 0.0025
539 PURPURA 22 0.0025
540 ROAD TRAFFIC ACCIDENT 104 0.0025
541 HEART RATE INCREASED 246 0.0025
542 HEPATIC ENCEPHALOPATHY 23 0.0025
543 IMPAIRED DRIVING ABILITY 28 0.0025
544 SKIN DISCOLOURATION 113 0.0025
545 CARDIAC DISORDER 230 0.0025
546 GASTROINTESTINAL PAIN 27 0.0025
547 WHITE BLOOD CELL COUNT DECREASED 266 0.0025
548 MOTOR DYSFUNCTION 25 0.0025
549 HALLUCINATION 184 0.0024
550 MUSCLE SPASMS 448 0.0024
551 SMALL INTESTINAL OBSTRUCTION 30 0.0024
552 HICCUPS 20 0.0024
553 SPINAL OPERATION 30 0.0024
554 MASS 34 0.0024
555 RESPIRATORY DISTRESS 67 0.0024
556 FATIGUE 1887 0.0024
557 VISION BLURRED 332 0.0024
558 MUSCULOSKELETAL DISORDER 46 0.0024
559 JAUNDICE 65 0.0024
560 POOR QUALITY SLEEP 52 0.0024
561 BLINDNESS UNILATERAL 34 0.0024
562 FEELING COLD 67 0.0024
563 PHARYNGEAL OEDEMA 37 0.0024
564 DYSPNOEA 1359 0.0024
565 PAIN IN EXTREMITY 707 0.0024
566 FLUSHING 243 0.0024
567 CLOSTRIDIUM DIFFICILE INFECTION 52 0.0024
568 SUBDURAL HAEMATOMA 34 0.0024
569 WOUND INFECTION 26 0.0024
570 RESPIRATORY DISORDER 71 0.0024
571 SCAB 27 0.0024
572 LETHARGY 136 0.0024
573 BEDRIDDEN 31 0.0024
574 CONTUSION 227 0.0024
575 CLOSTRIDIUM DIFFICILE COLITIS 25 0.0024
576 INCORRECT DOSE ADMINISTERED 538 0.0024
577 LOCAL SWELLING 41 0.0023
578 DYSPHAGIA 223 0.0023
579 OXYGEN SATURATION DECREASED 132 0.0023
580 PRODUCT QUALITY ISSUE 319 0.0023
581 TOXICITY TO VARIOUS AGENTS 396 0.0023
582 VERTIGO 143 0.0023
583 CARDIO-RESPIRATORY ARREST 98 0.0023
584 GASTROINTESTINAL INFECTION 21 0.0023
585 LACERATION 22 0.0023
586 COUGH 656 0.0023
587 PHARYNGITIS 29 0.0023
588 CHEST PAIN 433 0.0023
589 MALAISE 1025 0.0023
590 HAEMOPTYSIS 65 0.0023
591 TOOTH EXTRACTION 29 0.0023
592 RESPIRATORY TRACT CONGESTION 37 0.0023
593 SPINAL DISORDER 22 0.0023
594 SPUTUM DISCOLOURED 22 0.0023
595 FEELING HOT 142 0.0023
596 SOMNOLENCE 466 0.0023
597 FEELING ABNORMAL 554 0.0023
598 TENDERNESS 24 0.0023
599 PHOTOSENSITIVITY REACTION 38 0.0023
600 POST PROCEDURAL COMPLICATION 44 0.0023
601 MUSCULOSKELETAL PAIN 120 0.0023
602 MUSCLE ATROPHY 29 0.0023
603 NEUROLEPTIC MALIGNANT SYNDROME 27 0.0023
604 GAIT INABILITY 76 0.0023
605 HAEMORRHAGE INTRACRANIAL 34 0.0023
606 PRESCRIBED OVERDOSE 44 0.0023
607 THERAPEUTIC RESPONSE UNEXPECTED 102 0.0023
608 SWOLLEN TONGUE 71 0.0023
609 PNEUMOTHORAX 36 0.0023
610 FOOT FRACTURE 43 0.0023
611 ASPARTATE AMINOTRANSFERASE INCREASED 120 0.0023
612 CYST 28 0.0023
613 LIVER DISORDER 100 0.0023
614 BLOOD ALKALINE PHOSPHATASE INCREASED 56 0.0023
615 BACTERIAL INFECTION 42 0.0022
616 RESPIRATORY ARREST 62 0.0022
617 MIDDLE INSOMNIA 42 0.0022
618 GENERAL PHYSICAL HEALTH DETERIORATION 260 0.0022
619 STOMATITIS 136 0.0022
620 OSTEOPENIA 34 0.0022
621 MALIGNANT MELANOMA 30 0.0022
622 INJECTION SITE INDURATION 29 0.0022
623 NECK PAIN 125 0.0022
624 C-REACTIVE PROTEIN INCREASED 81 0.0022
625 ABASIA 55 0.0022
626 HERNIA 43 0.0022
627 SINUS CONGESTION 30 0.0022
628 INCORRECT DOSE ADMINISTERED BY DEVICE 58 0.0022
629 INJURY ASSOCIATED WITH DEVICE 45 0.0022
630 BLOOD LACTATE DEHYDROGENASE INCREASED 35 0.0022
631 BLOOD TEST ABNORMAL 31 0.0022
632 HYPOKINESIA 32 0.0022
633 MUSCULOSKELETAL CHEST PAIN 34 0.0022
634 TRANSFUSION 23 0.0022
635 DRUG EFFECT DECREASED 118 0.0022
636 PULMONARY FIBROSIS 42 0.0022
637 CHEST DISCOMFORT 224 0.0022
638 SINUS BRADYCARDIA 21 0.0022
639 PALPITATIONS 254 0.0022
640 UPPER RESPIRATORY TRACT INFECTION 100 0.0022
641 PERICARDIAL EFFUSION 50 0.0022
642 RASH GENERALISED 56 0.0022
643 SCAR 37 0.0022
644 SKIN LESION 59 0.0021
645 ALANINE AMINOTRANSFERASE INCREASED 132 0.0021
646 POST PROCEDURAL HAEMORRHAGE 25 0.0021
647 PRODUCT TASTE ABNORMAL 29 0.0021
648 BLOOD PRESSURE FLUCTUATION 51 0.0021
649 EJECTION FRACTION DECREASED 33 0.0021
650 EXTRA DOSE ADMINISTERED 86 0.0021
651 LYMPHADENOPATHY 75 0.0021
652 INSOMNIA 564 0.0021
653 HEPATOCELLULAR INJURY 30 0.0021
654 PRODUCTIVE COUGH 101 0.0021
655 SWELLING 198 0.0021
656 PRURITUS 809 0.0021
657 EYE DISORDER 69 0.0021
658 SINUSITIS 215 0.0021
659 LIVER FUNCTION TEST ABNORMAL 61 0.0021
660 SNEEZING 47 0.0021
661 STAPHYLOCOCCAL INFECTION 69 0.0021
662 EYE PAIN 118 0.0021
663 MUSCLE RIGIDITY 25 0.0021
664 CARDIOVASCULAR DISORDER 53 0.0021
665 THERAPY CESSATION 107 0.0021
666 SUDDEN DEATH 22 0.0021
667 COORDINATION ABNORMAL 29 0.0021
668 RESTLESSNESS 76 0.0021
669 PULMONARY ARTERIAL HYPERTENSION 30 0.0021
670 DERMATITIS ALLERGIC 26 0.0021
671 EXTRAPYRAMIDAL DISORDER 51 0.0021
672 BURNING SENSATION 144 0.0021
673 GINGIVAL BLEEDING 28 0.0020
674 AMNESIA 133 0.0020
675 SINUS TACHYCARDIA 29 0.0020
676 WRONG TECHNIQUE IN DRUG USAGE PROCESS 74 0.0020
677 HYPOAESTHESIA 304 0.0020
678 CARDIOMYOPATHY 30 0.0020
679 EAR INFECTION 54 0.0020
680 PARALYSIS 29 0.0020
681 PLASMA CELL MYELOMA 79 0.0020
682 ANHEDONIA 53 0.0020
683 PRODUCT PRESCRIBING ERROR 48 0.0020
684 OESOPHAGITIS 22 0.0020
685 CHILLS 236 0.0020
686 OROPHARYNGEAL PAIN 186 0.0020
687 ASPIRATION 22 0.0020
688 LIVER FUNCTION TEST INCREASED 43 0.0020
689 RASH MACULAR 70 0.0020
690 THROMBOSIS 161 0.0020
691 LABORATORY TEST ABNORMAL 59 0.0020
692 DELUSION 31 0.0020
693 DENTAL CARIES 22 0.0020
694 TOOTHACHE 36 0.0020
695 MYALGIA 337 0.0020
696 LIP SWELLING 66 0.0020
697 IMPAIRED HEALING 65 0.0020
698 RESTLESS LEGS SYNDROME 36 0.0020
699 SKIN DISORDER 66 0.0020
700 SEPTIC SHOCK 86 0.0020
701 DEEP VEIN THROMBOSIS 128 0.0020
702 BREAST PAIN 21 0.0020
703 EYELID PTOSIS 20 0.0020
704 HAEMATOCHEZIA 108 0.0020
705 INTRAOCULAR PRESSURE INCREASED 25 0.0020
706 APHASIA 59 0.0020
707 EYE INFECTION 22 0.0019
708 ORAL DISCOMFORT 27 0.0019
709 MOBILITY DECREASED 139 0.0019
710 NEURALGIA 47 0.0019
711 ACCIDENT 23 0.0019
712 EXPIRED PRODUCT ADMINISTERED 64 0.0019
713 DRUG ADMINISTRATION ERROR 59 0.0019
714 LUNG DISORDER 94 0.0019
715 HEPATIC ENZYME INCREASED 130 0.0019
716 PULMONARY EMBOLISM 181 0.0019
717 PANCYTOPENIA 106 0.0019
718 ADRENAL INSUFFICIENCY 23 0.0019
719 NIGHT SWEATS 61 0.0019
720 BLINDNESS 77 0.0019
721 GASTROINTESTINAL DISORDER 169 0.0019
722 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 88 0.0019
723 ABSCESS 30 0.0019
724 JOINT STIFFNESS 49 0.0019
725 BONE DISORDER 34 0.0019
726 ANGIOEDEMA 82 0.0019
727 BLOOD BILIRUBIN INCREASED 50 0.0018
728 TINNITUS 85 0.0018
729 GAMMA-GLUTAMYLTRANSFERASE INCREASED 41 0.0018
730 PARAESTHESIA 291 0.0018
731 DERMATITIS CONTACT 21 0.0018
732 BIPOLAR DISORDER 20 0.0018
733 ARTHRALGIA 764 0.0018
734 DEPRESSION 418 0.0018
735 SECRETION DISCHARGE 23 0.0018
736 ACUTE HEPATIC FAILURE 25 0.0018
737 THYROID CANCER 22 0.0018
738 ULCER 29 0.0018
739 ABDOMINAL PAIN LOWER 46 0.0018
740 LYMPHOCYTE COUNT DECREASED 32 0.0018
741 TREATMENT NONCOMPLIANCE 99 0.0018
742 HIP FRACTURE 58 0.0018
743 VASCULITIS 21 0.0018
744 ARTHROPATHY 100 0.0018
745 DEAFNESS 47 0.0018
746 DEVICE ISSUE 161 0.0018
747 HERPES ZOSTER 103 0.0018
748 NEUTROPHIL COUNT DECREASED 73 0.0018
749 DELIRIUM 62 0.0018
750 PERICARDITIS 30 0.0018
751 SLEEP DISORDER 126 0.0018
752 PSORIASIS 233 0.0018
753 GASTRIC DISORDER 61 0.0018
754 MOVEMENT DISORDER 57 0.0018
755 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 85 0.0018
756 SKIN CANCER 38 0.0018
757 DEVICE MALFUNCTION 124 0.0018
758 PRESCRIBED UNDERDOSE 35 0.0018
759 POLYNEUROPATHY 21 0.0018
760 PAIN 1076 0.0017
761 EYE SWELLING 65 0.0017
762 LYMPHOMA 27 0.0017
763 SENSORY DISTURBANCE 28 0.0017
764 THROMBOCYTOPENIA 195 0.0017
765 CHOKING 34 0.0017
766 BRAIN OEDEMA 22 0.0017
767 NASOPHARYNGITIS 320 0.0017
768 CONDITION AGGRAVATED 527 0.0017
769 PNEUMONITIS 47 0.0017
770 IRRITABLE BOWEL SYNDROME 37 0.0017
771 HYPOAESTHESIA ORAL 26 0.0017
772 APHONIA 24 0.0017
773 PYREXIA 595 0.0017
774 DERMATITIS 36 0.0017
775 LOWER LIMB FRACTURE 33 0.0017
776 INFUSION SITE PAIN 22 0.0017
777 TENDON RUPTURE 21 0.0017
778 THROAT TIGHTNESS 46 0.0017
779 INSURANCE ISSUE 26 0.0017
780 HIP ARTHROPLASTY 26 0.0017
781 RASH 740 0.0017
782 HEAD DISCOMFORT 30 0.0017
783 PALLOR 46 0.0017
784 SWELLING FACE 110 0.0017
785 ANXIETY 480 0.0017
786 HEADACHE 1057 0.0017
787 BACTERAEMIA 20 0.0017
788 PRODUCT ADMINISTRATION ERROR 34 0.0017
789 COGNITIVE DISORDER 78 0.0017
790 IMMUNE SYSTEM DISORDER 22 0.0017
791 ACTIVITIES OF DAILY LIVING IMPAIRED 33 0.0017
792 FREQUENT BOWEL MOVEMENTS 45 0.0017
793 KNEE ARTHROPLASTY 35 0.0017
794 DISEASE PROGRESSION 196 0.0017
795 NASAL CONGESTION 97 0.0016
796 SUICIDE ATTEMPT 100 0.0016
797 THROAT IRRITATION 74 0.0016
798 PHOTOPHOBIA 31 0.0016
799 EAR PAIN 32 0.0016
800 PRODUCT DOSE OMISSION ISSUE 483 0.0016
801 COVID-19 288 0.0016
802 QUALITY OF LIFE DECREASED 22 0.0016
803 FRACTURE 31 0.0016
804 PRODUCT PHYSICAL ISSUE 33 0.0016
805 MUSCULOSKELETAL STIFFNESS 143 0.0016
806 HEPATIC FAILURE 49 0.0016
807 DYSKINESIA 66 0.0016
808 CONTRAINDICATED PRODUCT ADMINISTERED 49 0.0016
809 PRODUCT USE ISSUE 304 0.0016
810 COMA 77 0.0016
811 HEPATOTOXICITY 36 0.0016
812 SKIN EXFOLIATION 136 0.0016
813 THINKING ABNORMAL 30 0.0016
814 ALOPECIA 316 0.0016
815 DEPRESSED MOOD 85 0.0016
816 PRODUCT DISPENSING ERROR 35 0.0016
817 WHEEZING 95 0.0016
818 INJECTION SITE RASH 49 0.0016
819 ORAL CANDIDIASIS 21 0.0016
820 ABNORMAL DREAMS 44 0.0016
821 ANOSMIA 23 0.0016
822 LACRIMATION INCREASED 48 0.0016
823 PROCEDURAL PAIN 44 0.0016
824 METASTASES TO BONE 26 0.0016
825 JOINT SWELLING 191 0.0016
826 NEOPLASM PROGRESSION 55 0.0016
827 INTENTIONAL DOSE OMISSION 45 0.0016
828 DISCOMFORT 96 0.0016
829 MENTAL IMPAIRMENT 38 0.0016
830 GLOSSODYNIA 35 0.0016
831 AGRANULOCYTOSIS 29 0.0016
832 ERECTILE DYSFUNCTION 40 0.0016
833 OSTEOPOROSIS 64 0.0016
834 FEBRILE NEUTROPENIA 103 0.0016
835 UNEVALUABLE EVENT 117 0.0015
836 LUNG INFECTION 24 0.0015
837 DIPLOPIA 40 0.0015
838 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 52 0.0015
839 URTICARIA 257 0.0015
840 INJECTION SITE SWELLING 117 0.0015
841 MYELODYSPLASTIC SYNDROME 22 0.0015
842 INFECTION 220 0.0015
843 THERAPY INTERRUPTED 108 0.0015
844 PSORIATIC ARTHROPATHY 61 0.0015
845 VIRAL INFECTION 50 0.0015
846 IRRITABILITY 90 0.0015
847 INTENTIONAL PRODUCT USE ISSUE 131 0.0015
848 HAEMORRHAGE 156 0.0015
849 DRUG INEFFECTIVE 1963 0.0015
850 EYE PRURITUS 50 0.0015
851 TENDONITIS 23 0.0015
852 AGITATION 109 0.0015
853 PRODUCT DOSE OMISSION IN ERROR 42 0.0015
854 DRY EYE 74 0.0015
855 FACE OEDEMA 25 0.0015
856 FIBROMYALGIA 36 0.0015
857 SEIZURE 171 0.0015
858 COLITIS 56 0.0015
859 RASH PAPULAR 33 0.0015
860 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 265 0.0015
861 BONE PAIN 86 0.0015
862 INJECTION SITE URTICARIA 36 0.0015
863 DRY SKIN 195 0.0015
864 INCORRECT DRUG ADMINISTRATION DURATION 41 0.0015
865 OSTEONECROSIS OF JAW 36 0.0015
866 OCULAR HYPERAEMIA 69 0.0015
867 NEOPLASM MALIGNANT 97 0.0015
868 ANGER 49 0.0014
869 TOOTH DISORDER 32 0.0014
870 ILLNESS 148 0.0014
871 INFLAMMATION 74 0.0014
872 INFLUENZA LIKE ILLNESS 118 0.0014
873 DISTURBANCE IN ATTENTION 77 0.0014
874 EMOTIONAL DISORDER 44 0.0014
875 MALIGNANT NEOPLASM PROGRESSION 146 0.0014
876 ASTHMA 160 0.0014
877 FEAR 38 0.0014
878 TACHYCARDIA 125 0.0014
879 IMPAIRED WORK ABILITY 30 0.0014
880 TRANSAMINASES INCREASED 31 0.0014
881 ERYTHEMA 286 0.0014
882 EYE IRRITATION 80 0.0014
883 PRODUCT SUBSTITUTION ISSUE 80 0.0014
884 ABNORMAL BEHAVIOUR 55 0.0014
885 INCORRECT PRODUCT ADMINISTRATION DURATION 30 0.0014
886 GASTRIC CANCER 35 0.0014
887 BONE MARROW FAILURE 28 0.0014
888 DEVICE USE ISSUE 24 0.0014
889 NEUTROPENIA 186 0.0014
890 PRODUCT AVAILABILITY ISSUE 31 0.0014
891 ACUTE RESPIRATORY DISTRESS SYNDROME 24 0.0014
892 RESPIRATORY TRACT INFECTION 35 0.0013
893 OVERDOSE 287 0.0013
894 FEMUR FRACTURE 41 0.0013
895 PANIC ATTACK 48 0.0013
896 INJECTION SITE WARMTH 27 0.0013
897 NEUROTOXICITY 23 0.0013
898 STEVENS-JOHNSON SYNDROME 29 0.0013
899 SEROTONIN SYNDROME 25 0.0013
900 OFF LABEL USE 1137 0.0013
901 INJECTION SITE ERYTHEMA 161 0.0013
902 MUSCLE TIGHTNESS 21 0.0013
903 INJECTION SITE REACTION 89 0.0013
904 INTENTIONAL DRUG MISUSE 27 0.0013
905 HEPATITIS 33 0.0013
906 LUNG NEOPLASM MALIGNANT 53 0.0013
907 SURGERY 75 0.0013
908 MULTIPLE FRACTURES 21 0.0013
909 BRAIN FOG 20 0.0013
910 HYPERSENSITIVITY 235 0.0013
911 DRUG INTOLERANCE 122 0.0013
912 LIVER INJURY 31 0.0013
913 HALLUCINATION, AUDITORY 20 0.0013
914 RASH MACULO-PAPULAR 28 0.0013
915 TOOTH LOSS 26 0.0013
916 PARANOIA 21 0.0012
917 ADVERSE EVENT 112 0.0012
918 DISABILITY 24 0.0012
919 MOOD ALTERED 33 0.0012
920 DEATH 1041 0.0012
921 BLADDER CANCER 71 0.0012
922 THERAPEUTIC RESPONSE DECREASED 73 0.0012
923 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 66 0.0012
924 ELECTROCARDIOGRAM QT PROLONGED 43 0.0012
925 NIGHTMARE 41 0.0012
926 HOSPITALISATION 182 0.0012
927 INJURY 83 0.0012
928 ADVERSE DRUG REACTION 106 0.0012
929 SUICIDAL IDEATION 108 0.0012
930 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 238 0.0012
931 WITHDRAWAL SYNDROME 49 0.0012
932 PAIN IN JAW 33 0.0012
933 RASH ERYTHEMATOUS 55 0.0011
934 MENTAL DISORDER 50 0.0011
935 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 21 0.0011
936 RHEUMATOID ARTHRITIS 128 0.0011
937 THERAPY NON-RESPONDER 50 0.0011
938 CONVULSION 63 0.0011
939 CRYING 40 0.0011
940 TARDIVE DYSKINESIA 31 0.0011
941 APPLICATION SITE PAIN 24 0.0011
942 ECZEMA 57 0.0011
943 ANAPHYLACTIC SHOCK 28 0.0011
944 MUSCLE TWITCHING 25 0.0011
945 LEUKOPENIA 54 0.0011
946 SKIN FISSURES 21 0.0011
947 ANAPHYLACTIC REACTION 59 0.0011
948 EPILEPSY 31 0.0010
949 PRODUCT USE IN UNAPPROVED INDICATION 247 0.0010
950 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 25 0.0010
951 ILL-DEFINED DISORDER 59 0.0010
952 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 69 0.0010
953 MUCOSAL INFLAMMATION 25 0.0010
954 EMOTIONAL DISTRESS 114 0.0009
955 MOOD SWINGS 30 0.0009
956 PRODUCT STORAGE ERROR 79 0.0009
957 NERVOUS SYSTEM DISORDER 28 0.0009
958 MIGRAINE 84 0.0009
959 VAGINAL HAEMORRHAGE 38 0.0009
960 PROSTATE CANCER 70 0.0009
961 BONE DENSITY DECREASED 27 0.0009
962 AGGRESSION 43 0.0009
963 THERAPEUTIC PRODUCT EFFECT DECREASED 38 0.0008
964 INFUSION RELATED REACTION 56 0.0008
965 SKIN BURNING SENSATION 59 0.0008
966 OSTEONECROSIS 27 0.0008
967 PSYCHOTIC DISORDER 24 0.0008
968 PHARMACEUTICAL PRODUCT COMPLAINT 21 0.0008
969 SKIN IRRITATION 37 0.0008
970 SEDATION 21 0.0008
971 ACCIDENTAL EXPOSURE TO PRODUCT 78 0.0008
972 PRODUCT ADHESION ISSUE 26 0.0007
973 DISEASE RECURRENCE 33 0.0007
974 BREAST CANCER 62 0.0007
975 DEVICE USE ERROR 23 0.0007
976 TREATMENT FAILURE 54 0.0007
977 MULTIPLE SCLEROSIS RELAPSE 43 0.0006
978 NO ADVERSE EVENT 109 0.0006
979 SYSTEMIC LUPUS ERYTHEMATOSUS 21 0.0006
980 DERMATITIS ATOPIC 31 0.0006
981 RENAL CANCER 26 0.0005
982 COLITIS ULCERATIVE 22 0.0005
983 MULTIPLE SCLEROSIS 23 0.0005
984 LOWER RESPIRATORY TRACT INFECTION 21 0.0005
985 DRUG ABUSE 37 0.0004
986 ACNE 33 0.0004
987 DRUG WITHDRAWAL SYNDROME 36 0.0004
988 DEVICE DIFFICULT TO USE 23 0.0003
989 DRUG DOSE OMISSION BY DEVICE 23 0.0003
990 MATERNAL EXPOSURE DURING PREGNANCY 23 0.0003
991 DRUG DEPENDENCE 34 0.0002